Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer
- PMID: 15191855
- DOI: 10.1016/j.amjsurg.2003.10.016
Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer
Abstract
Background: Although sentinel lymph node biopsy (SNLB) has become a standard ancillary to breast conservation, there remains a hesitancy to perform SLNB concomitant with mastectomy primarily because of concerns regarding reoperation for a positive SLN.
Methods: A retrospective review of 51 patients who underwent SLN biopsy concomitantly with mastectomy for invasive breast cancer was performed. In addition, a survey was sent to surgical oncologists who routinely perform SLNB in conjunction with mastectomy.
Results: The SLN was identified in 98% of patients, and an average of 2.4 SLNs/patient were removed. The SLN was positive in 14 patients (27%). Ten patients underwent axillary lymph node dissection as a second procedure; an average of 15.4 +/- 6 nodes were cleared, and there were no complications. Although techniques vary greatly among surgeons, the majority believe that a subsequent ALND procedure does not carry additional risk of morbidity.
Conclusions: Mastectomy and concomitant SLNB is a safe option for well-selected breast cancer patients. Results appear acceptable using a variety of techniques. Patients with a positive SLN can safely undergo completion axillary lymph node dissections. This includes patients who have undergone immediate reconstruction, but proper planning is needed to minimize potential risks.
Similar articles
-
Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.J Surg Oncol. 2003 Oct;84(2):63-7. doi: 10.1002/jso.10294. J Surg Oncol. 2003. PMID: 14502778
-
Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.J Surg Oncol. 2006 Feb 1;93(2):109-19. doi: 10.1002/jso.20406. J Surg Oncol. 2006. PMID: 16425290
-
Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.Am Surg. 2008 May;74(5):423-7. Am Surg. 2008. PMID: 18481500
-
Ductal carcinoma in situ: value of sentinel lymph node biopsy.J Surg Oncol. 2006 Oct 1;94(5):426-30. doi: 10.1002/jso.20578. J Surg Oncol. 2006. PMID: 16967457 Review.
-
Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.Ann Surg Oncol. 2008 May;15(5):1282-96. doi: 10.1245/s10434-008-9863-8. Epub 2008 Mar 11. Ann Surg Oncol. 2008. PMID: 18330650 Review.
Cited by
-
Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base.Ann Surg. 2005 Aug;242(2):281-9. doi: 10.1097/01.sla.0000171306.74366.22. Ann Surg. 2005. PMID: 16041220 Free PMC article.
-
Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.J Natl Cancer Inst Monogr. 2010;2010(41):145-9. doi: 10.1093/jncimonographs/lgq026. J Natl Cancer Inst Monogr. 2010. PMID: 20956820 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical